Replimune Group, Inc.

Nasdaq:REPL

Biological Products, (No Diagnostic Substances)·WOBURN, MA

Governanceproxy statements · beneficial ownership

Proxy Statements

13 shown

Filed	Form	Description
7/25/25	DEFA14A	DEFA14A	→
7/25/25	DEF 14A	DEF 14A	→
7/19/24	DEFA14A	DEFA14A	→
7/19/24	DEF 14A	DEF 14A	→
7/26/23	DEFA14A	DEFA14A	→
7/26/23	DEF 14A	DEF 14A	→
↓

Ownership Filings

40 shown

Filed	Form	Description
2/20/26	4	OWNERSHIP DOCUMENT	→
12/19/25	4	OWNERSHIP DOCUMENT	→
12/19/25	4	OWNERSHIP DOCUMENT	→
12/19/25	4	OWNERSHIP DOCUMENT	→
12/19/25	4	OWNERSHIP DOCUMENT	→
12/19/25	4	OWNERSHIP DOCUMENT	→
↓